Induction of cyclo-oxygenase-2 by cytokines in human pulmonary epithelial cells: regulation by dexamethasone.
about
Identification of human prostaglandin E synthase: a microsomal, glutathione-dependent, inducible enzyme, constituting a potential novel drug targetNonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysisCyclo-oxygenase-2: pharmacology, physiology, biochemistry and relevance to NSAID therapyAtorvastatin reduces lipopolysaccharide-induced expression of cyclooxygenase-2 in human pulmonary epithelial cells.Molecular Mechanisms Behind the Chemopreventive Effects of Anthocyanidins.Corticosteroids in acute respiratory failureNovel determinants of plaque instabilityEffects of non-steroidal anti-inflammatory drugs on cyclo-oxygenase and lipoxygenase activity in whole blood from aspirin-sensitive asthmatics vs healthy donors.Induction of cyclooxygenase-2 protein by lipoteichoic acid from Staphylococcus aureus in human pulmonary epithelial cells: involvement of a nuclear factor-kappa B-dependent pathwayNitric oxide (NO) modulation of PAF-induced cardiopulmonary action: interaction between NO synthase and cyclo-oxygenase-2 pathwaysEffects of prostaglandin E2 and cAMP elevating drugs on GM-CSF release by cultured human airway smooth muscle cells. Relevance to asthma therapy.Expression of the human glucocorticoid receptor alpha and beta isoforms in human respiratory epithelial cells and their regulation by dexamethasone.Prostaglandin E(2) regulates wound closure in airway epithelium.Cytokine-induced bronchoconstriction in precision-cut lung slices is dependent upon cyclooxygenase-2 and thromboxane receptor activation.Changes in airway resistance by simultaneous exposure to TNF-alpha and IL-1beta in perfused rat lungs.Cyclooxygenase-deficient mice. A summary of their characteristics and susceptibilities to inflammation and carcinogenesis.Endogenous inhibitory mechanisms in asthma.Asthma mediators: current views.Pulmonary cyclooxygenase-1 (COX-1) and COX-2 cellular expression and distribution after respiratory syncytial virus and parainfluenza virus infection.Molecular mechanisms of glucocorticoid action: what is important?Aspirin and other anti-inflammatory drugs.Role of COX-2 activity and CRP levels in patients with non-melanoma skin cancer. -765G>C PTGS2 polymorphism and NMSC risk.Lung myofibroblasts are characterized by down-regulated cyclooxygenase-2 and its main metabolite, prostaglandin E2.The effect of non-steroidal anti-inflammatory agents on behavioural changes and cytokine production following systemic inflammation: Implications for a role of COX-1Induction of cyclo-oxygenase-2 by cytokines in human cultured airway smooth muscle cells: novel inflammatory role of this cell type.Characterization of the induction of nitric oxide synthase and cyclo-oxygenase in rat aorta in organ culture.Regulation of the inducible cyclo-oxygenase pathway in human cultured airway epithelial (A549) cells by nitric oxide.Expression of cyclo-oxygenase-2 in human airway smooth muscle is associated with profound reductions in cell growthDown-regulation of microglial cyclo-oxygenase-2 and inducible nitric oxide synthase expression by lipocortin 1.Ex vivo assay to determine the cyclooxygenase selectivity of non-steroidal anti-inflammatory drugsInduction of eotaxin expression and release from human airway smooth muscle cells by IL-1beta and TNFalpha: effects of IL-10 and corticosteroids.The MAP kinase inhibitors, PD098059, UO126 and SB203580, inhibit IL-1beta-dependent PGE(2) release via mechanistically distinct processes.Validation of IKK beta as therapeutic target in airway inflammatory disease by adenoviral-mediated delivery of dominant-negative IKK beta to pulmonary epithelial cells.Increased expression of inducible nitric oxide synthase and cyclo-oxygenase-2 in the airway epithelium of asthmatic subjects and regulation by corticosteroid treatmentRottlerin enhances IL-1β-induced COX-2 expression through sustained p38 MAPK activation in MDA-MB-231 human breast cancer cellsOzone modulates IL-6 secretion in human airway epithelial and smooth muscle cellsRat pulmonary cyclooxygenase-2 expression in response to endotoxin challenge: differential regulation in the various types of cells in the lung.Elevated expression of cyclooxygenase-2 is a negative prognostic factor for overall survival in intrahepatic cholangiocarcinoma.Combination Treatment with Apricoxib and IL-27 Enhances Inhibition of Epithelial-Mesenchymal Transition in Human Lung Cancer Cells through a STAT1 Dominant PathwayPharmacological modulation of plaque instability.
P2860
Q22010153-1B00140C-A61A-4B36-8D73-88EEE07881CAQ24646764-AB6290CD-942A-48B8-8D2D-5049E101CE21Q24675327-46902DB6-625F-4E8E-A416-6D9897106B8BQ24796446-38B51055-7C2A-4514-BF99-3D72596E71C2Q24804805-A2D514A3-718B-4FDE-A638-934828430995Q28145486-869A2963-C78B-47A5-92D2-19E9D74C66F6Q28187632-DB6DF76B-D9B0-4DE3-B34B-9B55EEA011C8Q28194198-7D44A12D-B047-4D3B-9E2F-C8787AAA9376Q28361049-0E1D55C4-8DBE-42AA-A650-DB2AFBFB1E7EQ28362066-88386583-10BB-448A-83E8-B5AD27017A63Q31816362-0635C6F9-AD73-4A40-B322-97740204C0F9Q31816368-A9B2E46A-09E4-47B6-8CE7-6EDD15AD4A0FQ31834302-182D697B-C13F-47C3-93A5-43C89CE0A152Q31834433-06D1AD02-FFCE-4DAF-A58A-9964759B89ECQ32127815-C3F96D8C-83FB-4156-B7CF-54166C2A66F8Q33834295-3937DE74-9D28-4561-B93E-8C16B087B082Q33860266-C2AE47DD-B417-4E5E-9C1F-89CC764A6F44Q33861545-284CD4A1-BF4D-487F-ABC1-5ACD5F79EB06Q33905199-2C77D7F9-EA4B-4CE3-B44D-E95786B354BEQ33944529-49A9C004-E149-4CD7-93E8-2D72FFBC372AQ34036177-CBAACDD8-C563-4846-902A-545D9DD074B5Q34096844-8215626B-9601-4862-8D4D-17C9746AAD00Q34766530-4B284A53-F381-4DC5-A3E9-B1F769F9F836Q34993643-C6DF1D62-F7B5-499B-A276-FB436D77165DQ35025801-EAC2EDC9-B152-48A7-9B07-0226B19A42BCQ35026005-6DB64DA7-1306-48B1-8EDE-3A2990D9E621Q35026474-E230DF62-49B0-4956-9EEC-73C238283037Q35028099-4605910C-6FD0-456F-B4D5-0A36028DA2FDQ35028587-995040E8-D83B-4137-B56A-0E50A02009AEQ35028734-5ACA8396-8D44-474B-95BE-C75A5DD559ADQ35029115-428EB0DB-3D24-4582-B80C-784AD664D891Q35042474-B8C80929-29CB-48E6-B8E7-DAEF17556D35Q35048843-AC997518-EE94-4BEF-B022-1DD5215147D7Q35534500-16A11A68-3B80-4935-87FD-A24781A19B29Q35667259-073ACE8A-E6F7-4EA9-84FA-EFCDBEBE1E08Q35776527-394312D4-17F2-440C-B823-6CAE599CE92AQ35809968-4BF0B26C-C720-44F2-AA83-0D537C468CE6Q35837128-A3E96EDC-AB9E-47B9-9651-40D4FCEB6A9AQ36218965-50A8174B-2C37-4F81-99F0-F3131500209BQ36283516-1CBA34A9-CC2E-4FF0-9793-4610CD601368
P2860
Induction of cyclo-oxygenase-2 by cytokines in human pulmonary epithelial cells: regulation by dexamethasone.
description
1994 nî lūn-bûn
@nan
1994 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Induction of cyclo-oxygenase-2 ...... : regulation by dexamethasone.
@ast
Induction of cyclo-oxygenase-2 ...... : regulation by dexamethasone.
@en
Induction of cyclo-oxygenase-2 ...... : regulation by dexamethasone.
@nl
type
label
Induction of cyclo-oxygenase-2 ...... : regulation by dexamethasone.
@ast
Induction of cyclo-oxygenase-2 ...... : regulation by dexamethasone.
@en
Induction of cyclo-oxygenase-2 ...... : regulation by dexamethasone.
@nl
prefLabel
Induction of cyclo-oxygenase-2 ...... : regulation by dexamethasone.
@ast
Induction of cyclo-oxygenase-2 ...... : regulation by dexamethasone.
@en
Induction of cyclo-oxygenase-2 ...... : regulation by dexamethasone.
@nl
P2093
P2860
P1476
Induction of cyclo-oxygenase-2 ...... : regulation by dexamethasone.
@en
P2093
Akarasereenont P
Belvisi MG
Croxtall J
Mitchell JA
Robbins RA
P2860
P304
P356
10.1111/J.1476-5381.1994.TB17093.X
P407
P577
1994-11-01T00:00:00Z